Note on figures cited below. Some statistics in this article come from the V12 universe cohort (227,594 BUY filings, period through 2024). Since 2025-01-01 the live out-of-sample BUY universe (28 markets) shows a 52.96 percent win rate and a +8.59 percent mean 90-day return on 20,688 filings. See methodology for the current numbers and the STRATEGY_PROOF block for the frozen audit reference.
UK PDMR law still looks like Brussels, but the FCA has found distinctly British ways to make it sting.
Brexit did not blow up the UK regime for persons discharging managerial responsibilities, the people everyone still calls PDMRs because nobody has time for full nouns. The legal skeleton remained recognisably European. The UK onshored the Market Abuse Regulation, retained the familiar Article 19 machinery, and kept the three business day deadline for notifications of transactions by PDMRs and closely associated persons.
That is the easy part.
The harder, and more interesting, question is whether the UK now enforces that copied regime differently enough that issuers, directors, and investors should care. The short answer is yes. Not because the statutory text suddenly became exotic, but because enforcement is not a photocopying exercise. It is a matter of supervisory priorities, public messaging, case selection, and appetite for visible sanctions.
The article's angle, public censures versus the ESMA register over 2020 to 2025, runs into a practical constraint. Our own filings database currently shows 0 UK declarations from the provided query, so there is no proprietary filing panel here to quantify UK PDMR activity or lateness rates. That is annoying, but not fatal. It simply means we should be disciplined and stick to what can be shown from primary legal and regulatory sources.
The result is a more regulatory piece than a market microstructure one. Sometimes the plumbing matters more than the flow.
The market abuse regime that applies in the UK today is commonly called UK MAR. It is not a new invention. It is the onshored version of the EU Market Abuse Regulation, retained in domestic law through the European Union (Withdrawal) Act 2018 and then amended so the references point to UK institutions rather than EU ones.
For PDMR disclosures, the centre of gravity remains Article 19. The obligations are familiar:
This continuity was deliberate. The UK did not want to create a fresh market abuse code in the middle of a broader post-Brexit legal migration. Firms wanted continuity, investors wanted continuity, and regulators generally prefer not to rebuild the engine while driving on the motorway.
Where things changed was governance. In the EU, ESMA coordinates, issues Q&A and guidelines, and sits within a network of national competent authorities. In the UK, the FCA now occupies a more self-contained role. It interprets, supervises, and enforces UK MAR inside a domestic framework, with fewer formal incentives to maintain alignment for alignment's sake.
That does not mean instant divergence. Financial regulation tends to drift rather than jump. But drift matters. A copied rule can produce different outcomes when one supervisor is more willing to publish censure notices, more willing to frame controls failures as governance failures, or more willing to use enforcement to send a message.
One underappreciated point is that PDMR compliance is often shaped less by the regulation itself than by the accompanying guidance, forms, systems, and supervisory expectations. Issuers rarely ask, "What does Article 19 literally say?" They ask, "What will the regulator think if we file on day three at 11:58 p.m. after a board member forgot to tell us?"
That is where post-Brexit divergence can emerge without a dramatic statutory amendment. The FCA can emphasise controls, escalation, and personal accountability in ways that differ from the practical tone seen across EU member states. Same legal source material, different house style.
| Market | Regulator | Rule | Deadline | Notes |
|---|---|---|---|---|
| UK | FCA | UK MAR Art 19 | T+3 business days | Onshored EU MAR. FCA Handbook and supervisory communications shape practice. |
| FR | AMF | MAR Art 19 | T+3 business days | EU MAR applies via French framework. ESMA coordination remains relevant. |
| DE | BaFin | MAR Art 19 | T+3 business days | Same EU baseline, local enforcement style and publication practice differ. |
A public censure is a peculiar regulatory instrument. It is less expensive than a large fine, but often more memorable. Finance professionals can survive many things. Search results are not one of them.
Under the Financial Services and Markets Act framework, the FCA has long had the ability to publish statements of misconduct, including public censures, in appropriate cases. In market abuse and disclosure matters, that power can be especially effective because the audience is not merely the subject of the sanction. It is every listed company secretary, general counsel, sponsor, and compliance officer reading the notice over coffee and deciding to tighten their internal process before lunch.
The UK post-Brexit story is therefore not simply whether the FCA issues more penalties than its continental peers. It is whether it uses publication, naming, and narrative more assertively. That is the "different teeth" point. A copied regime can bite harder if the supervisor is more willing to show the bite marks.
The user angle asks about the "number of public censures vs ESMA register over 2020-2025". Sensible premise, awkward dataset.
ESMA maintains sanctions information under the MAR framework, but the register is not a perfect comparator for UK post-Brexit practice for at least three reasons:
So yes, one can compare counts, but one should not pretend that a count alone tells the story. A regulator that publishes fewer but more detailed censures may have more behavioural impact than one that produces a longer register with thinner narrative.
A recurring feature of UK enforcement over the past decade is the FCA's focus on systems and controls. That matters for PDMR disclosures because late or inaccurate notifications are rarely just the fault of one forgetful executive. They often reveal a process problem:
The FCA tends to frame such failures not as administrative trivia but as governance weaknesses. That is a different rhetorical and enforcement posture from treating a late filing as a clerical mishap. Again, same legal words, different institutional temperament.
Because the supplied data includes no UK filings and no precompiled sanction counts, this article cannot responsibly state a definitive 2020-2025 tally of UK PDMR-related public censures against an ESMA total. That is not evasive. It is called not making things up, a habit worth preserving.
What can be said is that the FCA publishes final notices, decision notices, and public censures in a structured way, while ESMA provides a sanctions data framework and national authorities publish their own enforcement outputs. A proper count would require a hand-built dataset with at least these fields:
That sounds tedious because it is. It is also the only way to avoid comparing apples with filing cabinets.
If one were constructing the 2020-2025 series, the workflow would be straightforward:
This is not glamorous work. It is, however, the difference between analysis and decorative spreadsheeting.
Even with a careful count, divergence may still be understated. Enforcement style shows up in places that a sanctions register does not capture well:
A regulator can alter behaviour without materially changing the number of formal sanctions. If the FCA becomes more explicit about personal responsibility, controls expectations, and publication policy, firms may react long before the count of censures moves.
That is one reason post-Brexit regulatory divergence can feel larger in practice than it looks in legal comparison tables.
For UK issuers, the challenge is not understanding the concept of PDMR disclosure. The concept has been around for years. The burden is operational discipline.
A robust UK process should include, at minimum:
None of this is novel. That is the point. Most avoidable PDMR failures are failures of routine.
Executives often think a one-off late notification is embarrassing but minor. Regulators tend to ask a different question: what allowed this to happen?
If the answer is "the director was travelling", the FCA is unlikely to be impressed. Senior managers in listed companies are expected to have systems. If the answer is "the company had no reliable process for identifying closely associated persons", that is worse. It suggests the issuer did not build the compliance machinery required by a public market listing.
The practical implication is simple. Directors should treat PDMR reporting as a standing governance obligation, not a diary item.
For investors, PDMR disclosure failures are rarely thesis-changing on their own. But they can be useful governance signals.
A late or corrected filing may indicate:
One breach proves little. A pattern is more interesting. In a world where many governance indicators are soft and qualitative, disclosure timeliness is at least observable.
The UK has not shown much appetite to scrap the PDMR framework outright. The more plausible path is selective adjustment: consultation on disclosure burdens, refinements to listing and prospectus architecture, and small changes to guidance that alter compliance practice at the margin.
That means the most important divergence may remain institutional rather than legislative. The FCA can become more interventionist, more publication-oriented, or more willing to frame issuer failings as broader market integrity issues. None of that requires rewriting Article 19 from first principles.
Post-Brexit, UK regulators face a familiar political balancing act. They are asked to support competitiveness and growth, but also to maintain market integrity and public confidence. One way to square that circle is to keep the substantive rules broadly stable while using targeted, visible enforcement to remind the market that standards still matter.
Public censure fits that model rather well. It is cheaper than endless rulemaking, more visible than private supervision, and often easier to justify politically than very large fines for technical disclosure breaches. Dry, yes. Effective, often.
The unresolved empirical question is whether the FCA's post-Brexit posture has actually produced a higher rate of public censure, or simply a different quality of enforcement communication. That requires the count we do not yet have.
It also requires separating PDMR cases from the broader MAR universe. Market abuse headlines are usually about insider dealing and manipulation, not directors filing a dealing form late. But for listed company compliance teams, the latter is where the daily friction lives.
If Sigma Journal were to build the promised 2020-2025 comparison properly, the scoreboard should include at least four metrics:
That would give a better picture of "teeth" than a single sanctions count.
The ideal denominator would be the number of PDMR filings by market and year. That would allow rates rather than raw totals. Unfortunately, our current UK filing query returns zero, so that denominator is absent here. Until that is fixed, any comparison of UK and EU sanction counts should be treated as descriptive, not normalised.
That matters because a market with more filings may naturally produce more breaches, even if compliance quality is unchanged. Regulators do not issue sanctions in a vacuum. They issue them against an activity base.
The concrete next step is therefore not another abstract debate about sovereignty. It is a data build: compile FCA public censures and final notices for UK MAR Article 19 matters from 2020 to 2025, map them against ESMA-linked national sanction publications for the same period, and then test whether the UK's post-Brexit difference is one of frequency, severity, or merely prose style. My suspicion is that the prose style matters more than lawyers admit. The market, as usual, notices tone before it notices doctrine.
Editorial note, this article was assembled without live web research (Grok unavailable in this generation pass). Evergreen sources are cited above; numerical claims are pulled from our own database snapshot as of 2026-05-17.
The analysis of the UK PDMR law post-Brexit reveals a striking absence of priced trades within our UK dataset, resulting in a sample size of zero for the BUY cohort over a 90-day horizon. This lack of data underscores the challenges faced by market participants in navigating the new regulatory landscape. In contrast, the global universe, comprising 227,594 BUY filings across 17 markets, demonstrates an aggregate mean 90-day return of -1.70% and an aggregate Sharpe ratio of -0.08. These figures suggest that, while the broader market struggles, the UK market's compliance and enforcement changes may further complicate investment strategies. The absence of actionable data in the UK highlights the need for ongoing scrutiny of how these regulatory shifts impact market performance and investor behavior. It is important to note that the findings are based on a limited sample size and a specific time horizon.
Last reviewed · 2026-05-18 · By Simon Azoulay · Sources, SEC EDGAR, AMF BDIF, and 28 other regulators.
Brad Kitchen bought about EUR 24,012 of Element One stock as Canada’s natural hydrogen and critical minerals story keeps...
Don Gray bought Petrus Resources shares into a soft Canadian energy tape. Here is how the cluster reads against peers, o...
Predilife founder Stéphane Ragusa bought again as European life sciences stays cautious, with ALPRE still a micro-cap an...
Arqit’s CEO sold after a strong run in quantum names. The filing lands against weak revenue, a fresh cluster of sales, a...
Cardlytics CEO Amit Gupta sold near $4.39 after a reverse split. We read the cluster against a shaky ad-tech tape and sm...
GreenPower’s CEO bought about EUR 1.01m of stock as EV demand stays uneven. We read the filing against Workhorse and the...
